203 related articles for article (PubMed ID: 32882033)
1. Dynamics of Islet Autoantibodies During Prospective Follow-Up From Birth to Age 15 Years.
Pöllänen PM; Ryhänen SJ; Toppari J; Ilonen J; Vähäsalo P; Veijola R; Siljander H; Knip M
J Clin Endocrinol Metab; 2020 Dec; 105(12):e4638-51. PubMed ID: 32882033
[TBL] [Abstract][Full Text] [Related]
2. Hierarchical Order of Distinct Autoantibody Spreading and Progression to Type 1 Diabetes in the TEDDY Study.
Vehik K; Bonifacio E; Lernmark Å; Yu L; Williams A; Schatz D; Rewers M; She JX; Toppari J; Hagopian W; Akolkar B; Ziegler AG; Krischer JP;
Diabetes Care; 2020 Sep; 43(9):2066-2073. PubMed ID: 32641373
[TBL] [Abstract][Full Text] [Related]
3. Predicting Islet Cell Autoimmunity and Type 1 Diabetes: An 8-Year TEDDY Study Progress Report.
Krischer JP; Liu X; Vehik K; Akolkar B; Hagopian WA; Rewers MJ; She JX; Toppari J; Ziegler AG; Lernmark Å;
Diabetes Care; 2019 Jun; 42(6):1051-1060. PubMed ID: 30967432
[TBL] [Abstract][Full Text] [Related]
4. Predictors of Progression From the Appearance of Islet Autoantibodies to Early Childhood Diabetes: The Environmental Determinants of Diabetes in the Young (TEDDY).
Steck AK; Vehik K; Bonifacio E; Lernmark A; Ziegler AG; Hagopian WA; She J; Simell O; Akolkar B; Krischer J; Schatz D; Rewers MJ;
Diabetes Care; 2015 May; 38(5):808-13. PubMed ID: 25665818
[TBL] [Abstract][Full Text] [Related]
5. Characteristics of children diagnosed with type 1 diabetes before vs after 6 years of age in the TEDDY cohort study.
Krischer JP; Liu X; Lernmark Å; Hagopian WA; Rewers MJ; She JX; Toppari J; Ziegler AG; Akolkar B;
Diabetologia; 2021 Oct; 64(10):2247-2257. PubMed ID: 34291312
[TBL] [Abstract][Full Text] [Related]
6. First-appearing islet autoantibodies for type 1 diabetes in young children: maternal life events during pregnancy and the child's genetic risk.
Johnson SB; Lynch KF; Roth R; Lundgren M; Parikh HM; Akolkar B; Hagopian W; Krischer J; Rewers M; She JX; Toppari J; Ziegler AG; Lernmark Å;
Diabetologia; 2021 Mar; 64(3):591-602. PubMed ID: 33404683
[TBL] [Abstract][Full Text] [Related]
7. Possible heterogeneity of initial pancreatic islet beta-cell autoimmunity heralding type 1 diabetes.
Lernmark Å; Akolkar B; Hagopian W; Krischer J; McIndoe R; Rewers M; Toppari J; Vehik K; Ziegler AG;
J Intern Med; 2023 Aug; 294(2):145-158. PubMed ID: 37143363
[TBL] [Abstract][Full Text] [Related]
8. Novel autoantibodies to the β-cell surface epitopes of ZnT8 in patients progressing to type-1 diabetes.
Gu Y; Merriman C; Guo Z; Jia X; Wenzlau J; Li H; Li H; Rewers M; Yu L; Fu D
J Autoimmun; 2021 Aug; 122():102677. PubMed ID: 34130115
[TBL] [Abstract][Full Text] [Related]
9. Association Between Early-Life Antibiotic Use and the Risk of Islet or Celiac Disease Autoimmunity.
Kemppainen KM; Vehik K; Lynch KF; Larsson HE; Canepa RJ; Simell V; Koletzko S; Liu E; Simell OG; Toppari J; Ziegler AG; Rewers MJ; Lernmark Å; Hagopian WA; She JX; Akolkar B; Schatz DA; Atkinson MA; Blaser MJ; Krischer JP; Hyöty H; Agardh D; Triplett EW;
JAMA Pediatr; 2017 Dec; 171(12):1217-1225. PubMed ID: 29052687
[TBL] [Abstract][Full Text] [Related]
10. Identification of non-HLA genes associated with development of islet autoimmunity and type 1 diabetes in the prospective TEDDY cohort.
Sharma A; Liu X; Hadley D; Hagopian W; Chen WM; Onengut-Gumuscu S; Törn C; Steck AK; Frohnert BI; Rewers M; Ziegler AG; Lernmark Å; Toppari J; Krischer JP; Akolkar B; Rich SS; She JX;
J Autoimmun; 2018 May; 89():90-100. PubMed ID: 29310926
[TBL] [Abstract][Full Text] [Related]
11. Zinc transporter 8 autoantibodies complement glutamic acid decarboxylase and insulinoma-associated antigen-2 autoantibodies in the identification and characterization of Japanese type 1 diabetes.
Kawasaki E; Oikawa Y; Okada A; Kanatsuna N; Kawamura T; Kikuchi T; Terasaki J; Miura J; Ito Y; Hanafusa T
J Diabetes Investig; 2020 Sep; 11(5):1181-1187. PubMed ID: 32175683
[TBL] [Abstract][Full Text] [Related]
12. Impact of Age and Antibody Type on Progression From Single to Multiple Autoantibodies in Type 1 Diabetes Relatives.
Bosi E; Boulware DC; Becker DJ; Buckner JH; Geyer S; Gottlieb PA; Henderson C; Kinderman A; Sosenko JM; Steck AK; Bingley PJ;
J Clin Endocrinol Metab; 2017 Aug; 102(8):2881-2886. PubMed ID: 28531305
[TBL] [Abstract][Full Text] [Related]
13. Gestational respiratory infections interacting with offspring HLA and CTLA-4 modifies incident β-cell autoantibodies.
Lynch KF; Lee HS; Törn C; Vehik K; Krischer JP; Larsson HE; Haller MJ; Hagopian WA; Rewers MJ; She JX; Simell OG; Toppari J; Ziegler AG; Akolkar B; Hyöty H; Bonifacio E; Lernmark Å;
J Autoimmun; 2018 Jan; 86():93-103. PubMed ID: 28941965
[TBL] [Abstract][Full Text] [Related]
14. Reversion of β-Cell Autoimmunity Changes Risk of Type 1 Diabetes: TEDDY Study.
Vehik K; Lynch KF; Schatz DA; Akolkar B; Hagopian W; Rewers M; She JX; Simell O; Toppari J; Ziegler AG; Lernmark Å; Bonifacio E; Krischer JP;
Diabetes Care; 2016 Sep; 39(9):1535-42. PubMed ID: 27311490
[TBL] [Abstract][Full Text] [Related]
15. Clinical and biological characteristics of diabetic patients under age 40 in Cameroon: relation to autoantibody status and comparison with Belgian patients.
Asanghanwa M; Gorus FK; Weets I; der Auwera BV; Aminkeng F; Mbunwe E; Goubert P; Verhaeghen K; Sobngwi E; Wenzlau JM; Hutton JC; Pipeleers DG; Keymeulen B; Mbanya JC; van Schravendijk C
Diabetes Res Clin Pract; 2014 Jan; 103(1):97-105. PubMed ID: 24332797
[TBL] [Abstract][Full Text] [Related]
16. Predicting progression to type 1 diabetes from ages 3 to 6 in islet autoantibody positive TEDDY children.
Jacobsen LM; Larsson HE; Tamura RN; Vehik K; Clasen J; Sosenko J; Hagopian WA; She JX; Steck AK; Rewers M; Simell O; Toppari J; Veijola R; Ziegler AG; Krischer JP; Akolkar B; Haller MJ;
Pediatr Diabetes; 2019 May; 20(3):263-270. PubMed ID: 30628751
[TBL] [Abstract][Full Text] [Related]
17. Plasma Metabolome and Circulating Vitamins Stratified Onset Age of an Initial Islet Autoantibody and Progression to Type 1 Diabetes: The TEDDY Study.
Li Q; Liu X; Yang J; Erlund I; Lernmark Å; Hagopian W; Rewers M; She JX; Toppari J; Ziegler AG; Akolkar B; Krischer JP;
Diabetes; 2021 Jan; 70(1):282-292. PubMed ID: 33106256
[TBL] [Abstract][Full Text] [Related]
18. Maternal dietary supplement use and development of islet autoimmunity in the offspring: TEDDY study.
Silvis K; Aronsson CA; Liu X; Uusitalo U; Yang J; Tamura R; Lernmark Å; Rewers M; Hagopian W; She JX; Simell O; Toppari J; Ziegler A; Akolkar B; Krischer J; Virtanen SM; Norris JM;
Pediatr Diabetes; 2019 Feb; 20(1):86-92. PubMed ID: 30411443
[TBL] [Abstract][Full Text] [Related]
19. Association of Early Exposure of Probiotics and Islet Autoimmunity in the TEDDY Study.
Uusitalo U; Liu X; Yang J; Aronsson CA; Hummel S; Butterworth M; Lernmark Å; Rewers M; Hagopian W; She JX; Simell O; Toppari J; Ziegler AG; Akolkar B; Krischer J; Norris JM; Virtanen SM;
JAMA Pediatr; 2016 Jan; 170(1):20-8. PubMed ID: 26552054
[TBL] [Abstract][Full Text] [Related]
20. The 6 year incidence of diabetes-associated autoantibodies in genetically at-risk children: the TEDDY study.
Krischer JP; Lynch KF; Schatz DA; Ilonen J; Lernmark Å; Hagopian WA; Rewers MJ; She JX; Simell OG; Toppari J; Ziegler AG; Akolkar B; Bonifacio E;
Diabetologia; 2015 May; 58(5):980-7. PubMed ID: 25660258
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
